Aims/Hypothesis One of the hallmarks of diabetes is impaired endothelial function. Previous
studies showed that HDL can exert protective effects on endothelium stimulating NO …

Background Functional properties of high density lipoproteins (HDL) are increasingly
recognized to play a physiological role in atheroprotection. Type 2 diabetes mellitus (T2DM) …

Background—High-density lipoprotein (HDL)–raising therapies are currently under intense
evaluation, but the effects of HDL may be highly heterogeneous. We therefore compared the …

Coronary artery disease, the leading cause of death in the developed and developing
countries, is prevalent in diabetes mellitus with 68% cardiovascular disease (CVD)-related …

Abstract Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by absence
of insulin secretion due to destruction of the pancreatic beta-cells. Patients with T1D exhibit …

Aims/hypothesis The prevalence of atherosclerosis is increased in type 1 diabetes despite
normal-to-high HDL-cholesterol levels. The cholesterol efflux capacity (CEC) of HDL is a …

Background Inflammation is a pathophysiological factor in diabetes and its cardiovascular
complications. High-density lipoprotein (HDL) suppresses inflammation in healthy …

The vascular endothelium serves as a barrier between the intravascular and extravascular
compartments. High-density lipoproteins (HDL) have two kinds of interactions with this …

Objective To assess whether, in type 2 diabetes (T2D) patients, lipidomic abnormalities in
high-density lipoprotein (HDL) are associated with impaired cholesterol efflux capacity and …

Disordered neovascularization and impaired wound healing are important contributors to
diabetic vascular complications. We recently showed that high-density lipoproteins (HDLs) …